Thailand Dyspepsia Guidelines: 2018
Autor: | Olarn Wiwattanachang, Ratha-Korn Vilaichone, Suriya Chakkaphak, Jarin Rojborwonwitaya, Rattana Boonsirichan, Jaksin Sottisuporn, Taned Chitapanarux, Pisaln Mairiang, Sombat Treeprasertsuk, Varocha Mahachai, Monthira Maneerattanaporn, Inchaya Sansak, Uayporn Kaosombatwattana, Supphamat Chirnaksorn, Rapat Pittayanon, Surapon Chuenrattanakul, Wanich Piyanirun, Pochamana Phisalprapa, Somchai Leelakusolvong, Chalermrat Bunchorntavakul |
---|---|
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
MEDLINE Disease Review Guideline 03 medical and health sciences 0302 clinical medicine medicine Dyspepsia Grading (education) Irritable bowel syndrome business.industry digestive oral and skin physiology Gastroenterology Opinion leadership Evidence-based medicine medicine.disease Thailand digestive system diseases Clinical Practice 030220 oncology & carcinogenesis Family medicine 030211 gastroenterology & hepatology Neurology (clinical) business |
Zdroj: | Journal of Neurogastroenterology and Motility |
ISSN: | 2093-0879 |
Popis: | The management of dyspepsia in limited-resource areas has not been established. In 2017, key opinion leaders throughout Thailand gathered to review and evaluate the current clinical evidence regarding dyspepsia and to develop consensus statements, rationales, levels of evidence, and grades of recommendation for dyspepsia management in daily clinical practice based on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. This guideline is mainly focused on the following 4 topics: (1) evaluation of patients with dyspepsia, (2) management, (3) special issues (overlapping gastroesophageal reflux disease/ irritable bowel syndrome and non-steroidal anti-inflammatory drug/aspirin use), and (4) long-term follow-up and management to provide guidance for physicians in Thailand and other limited-resource areas managing such patients. (J Neurogastroenterol Motil 2019;25:15-26) |
Databáze: | OpenAIRE |
Externí odkaz: |